CN Stock MarketDetailed Quotes

301293 Sanbo Hospital Management

Watchlist
  • 50.41
  • +0.02+0.04%
Market Closed Dec 20 15:00 CST
10.38BMarket Cap94.76P/E (TTM)

Sanbo Hospital Management Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Assets
Current assets
Money funds
-18.44%755.15M
-25.32%1.13B
96.47%1.15B
36.93%822.12M
--925.85M
274.14%1.51B
--583.7M
29.86%600.39M
----
19.70%403.78M
Transactional financial assets
-23.07%509.25M
448.05%329.27M
829.31%372.37M
7,523.92%762.41M
--662M
-57.22%60.08M
--40.07M
-88.91%10M
----
-43.90%140.45M
Notes receivable and accounts receivable
16.69%99.2M
-18.92%88.97M
-9.40%74.27M
39.69%96.68M
--85.01M
21.57%109.72M
--81.97M
-23.87%69.21M
----
33.49%90.26M
-Accounts receivable
16.69%99.2M
-18.92%88.97M
-9.40%74.27M
39.69%96.68M
--85.01M
21.57%109.72M
--81.97M
-23.87%69.21M
----
33.49%90.26M
Other receivables (including interest and dividends)
113.45%16.11M
-5.45%6.74M
-60.85%8.21M
-65.94%6.21M
--7.55M
-59.83%7.13M
--20.96M
4.59%18.23M
----
-1.63%17.75M
-Other receivable
----
-5.45%6.74M
----
----
----
-59.83%7.13M
----
4.59%18.23M
----
-1.63%17.75M
Contractual assets
--75.44K
--72.77K
--114.2K
--53.46K
----
----
----
----
----
----
Advance payment
-33.84%817.13K
27,689.39%722.52K
-88.64%1.1M
-99.34%69.52K
--1.24M
-99.97%2.6K
--9.67M
56.57%10.46M
----
37.13%7.87M
Inventories
29.73%46.94M
21.93%38.8M
31.38%39.6M
-1.14%31.34M
--36.18M
16.19%31.82M
--30.15M
11.57%31.7M
----
-2.84%27.38M
Other current assets
5.55%18.98M
32.44%18.33M
735.76%27.84M
570.89%14.73M
--17.98M
384.89%13.84M
--3.33M
-35.25%2.2M
----
63.22%2.85M
Total current assets
-16.67%1.45B
-7.05%1.61B
116.97%1.67B
133.58%1.73B
--1.74B
151.08%1.73B
--769.85M
6.13%742.19M
----
-2.63%690.35M
Non Current assets
Long-term equity investment
----
----
----
----
--10.73M
-0.42%10.52M
--10.53M
----
----
0.60%10.56M
Fixed assets
----
9.52%213.33M
----
----
----
-9.44%194.78M
----
-1.04%217.41M
----
3.57%215.08M
Constru in process
----
75.89%502.95M
----
----
----
41.84%285.95M
----
54.46%236.16M
----
138.33%201.6M
Intangible assets
-1.14%499.84M
-1.26%502.86M
25.44%503.42M
24.77%503.88M
--505.59M
24.41%509.29M
--401.32M
-2.54%403.84M
----
-2.46%409.37M
Goodwill
67.32%25.39M
67.32%25.39M
67.32%25.39M
67.32%25.39M
--15.17M
0.00%15.17M
--15.17M
0.00%15.17M
----
0.00%15.17M
Long deferred expense
302.10%101.64M
276.66%98.62M
239.15%91.1M
203.82%87.43M
--25.28M
-15.87%26.18M
--26.86M
-3.49%28.78M
----
-8.81%31.12M
Deferred tax assets
-36.85%9.29M
-3.40%14.74M
2.88%15.64M
3.00%14.76M
--14.71M
25.96%15.26M
--15.2M
20.50%14.33M
----
17.03%12.11M
Usufruct assets
-19.80%129.95M
-20.25%137.34M
-18.97%145.86M
-18.62%154.41M
--162.03M
-17.42%172.2M
--180M
-15.49%189.74M
----
6.83%208.54M
Other non current assets
130.84%28.55M
-36.50%8.78M
-19.26%8.18M
-89.66%9.44M
--12.37M
64.48%13.82M
--10.13M
625.51%91.23M
----
-44.13%8.4M
Total non current assets
24.45%1.56B
20.98%1.5B
28.91%1.42B
17.03%1.4B
--1.25B
11.80%1.24B
--1.1B
9.64%1.2B
----
12.05%1.11B
Total assets
0.59%3.01B
4.66%3.12B
65.12%3.09B
61.65%3.13B
62.36%2.99B
65.15%2.98B
--1.87B
8.27%1.94B
5.03%1.84B
5.93%1.8B
Liabilities
Current liabilities
Notes payable and accounts payable
-0.71%185.52M
5.39%209.59M
18.30%209.98M
52.11%252.58M
--186.84M
24.31%198.87M
--177.5M
17.59%166.05M
----
27.10%159.98M
-Accounts payable
-0.71%185.52M
5.39%209.59M
18.30%209.98M
52.11%252.58M
--186.84M
24.31%198.87M
--177.5M
17.59%166.05M
----
27.10%159.98M
Contract liabilities
-1.76%6.04M
6.27%8.21M
12.36%8M
15.14%6.15M
--6.15M
12.15%7.73M
--7.12M
4.72%5.34M
----
4.75%6.89M
Advance receipts
--72K
----
----
----
----
----
----
----
----
----
Salaries payable
23.12%77.27M
23.07%65.57M
28.29%50.25M
78.92%87.4M
--62.76M
36.38%53.28M
--39.17M
-32.05%48.85M
----
-22.31%39.06M
Taxs payable
-21.86%7.95M
26.15%13.2M
35.56%16.78M
116.52%11.07M
--10.17M
53.44%10.46M
--12.38M
96.27%5.11M
----
-35.45%6.82M
Other payable (including interest and dividends)
-2.51%31.02M
-23.72%28.84M
-9.65%32.85M
-42.24%44.61M
--31.82M
9.43%37.81M
--36.36M
108.44%77.23M
----
-10.61%34.55M
-Other payable
----
-23.72%28.84M
----
----
----
9.43%37.81M
----
108.44%77.23M
----
-10.61%34.55M
Non current liabilities due within one year
31.52%36.15M
2.49%38.31M
-14.76%30.67M
1.01%40.62M
--27.49M
12.76%37.38M
--35.98M
23.26%40.22M
----
48.26%33.15M
Total current liabilities
5.78%344.02M
5.26%363.72M
12.97%348.53M
29.06%442.43M
--325.23M
23.20%345.53M
--308.5M
18.01%342.8M
----
10.28%280.46M
Current liabilities
Long term account payable
----
3.20%14.67M
----
----
----
-11.28%14.22M
----
-11.28%13.89M
----
-9.73%16.03M
Specific account payable
----
14.44%3.02M
----
----
----
-52.60%2.64M
----
-36.56%3.5M
----
2.48%5.57M
Estimate liabilities
-56.09%11.74M
22.59%32.76M
26.88%33.98M
18.28%32.08M
--26.74M
-4.52%26.73M
--26.78M
-10.88%27.12M
----
-0.62%27.99M
Deferred tax liabilities
-98.31%19.05K
-92.72%76.98K
51.93%745.19K
--101.13K
--1.13M
56.77%1.06M
--490.47K
----
----
-40.20%674.22K
Long term deferred income
29.16%5.43M
34.84%5.55M
3.03%4.83M
-4.39%3.77M
--4.2M
-50.55%4.11M
--4.69M
-45.83%3.95M
----
-8.56%8.32M
Lease liabilities
-22.04%114.15M
-23.59%116.83M
-21.17%128.52M
-20.63%132.36M
--146.42M
-18.26%152.91M
--163.03M
-16.86%166.77M
----
4.86%187.06M
Total non current liabilities
-25.93%150.56M
-14.26%172.92M
-10.14%190.61M
-14.73%183.52M
--203.27M
-17.90%201.67M
--212.13M
-17.28%215.23M
----
2.36%245.64M
Total liabilities
-6.42%494.58M
-1.93%536.63M
3.56%539.14M
12.17%625.95M
-2.15%528.5M
4.01%547.2M
--520.63M
1.34%558.03M
1.82%540.12M
6.44%526.1M
Shareholders equity
Paid-in capital
30.00%205.99M
30.00%205.99M
33.33%158.45M
33.33%158.45M
--158.45M
33.33%158.45M
--118.84M
0.00%118.84M
----
0.00%118.84M
Capital reserve funds
-3.83%1.63B
-3.83%1.63B
147.08%1.69B
134.48%1.69B
--1.7B
150.82%1.7B
--685.35M
6.63%721.22M
----
0.05%676.35M
Surplus reserve funds
25.48%9.76M
25.48%9.76M
25.48%9.76M
25.48%9.76M
--7.78M
19.35%7.78M
--7.78M
19.35%7.78M
----
21.24%6.52M
Retained profit
20.16%554.85M
19.36%516.92M
20.01%499.37M
19.60%465.35M
--461.74M
20.43%433.08M
--416.12M
18.77%389.09M
----
19.83%359.62M
Less:Treasury stock
--104.19M
----
----
----
----
----
----
----
----
----
Shareholders equity without minority interests
-1.14%2.3B
2.98%2.36B
92.24%2.36B
87.94%2.32B
96.02%2.32B
97.69%2.3B
--1.23B
9.53%1.24B
--1.19B
5.54%1.16B
Minority interests
56.60%215.73M
60.44%214.2M
54.92%191.45M
27.49%183.44M
--137.76M
16.20%133.51M
--123.58M
29.91%143.89M
----
7.65%114.9M
Total shareholder equity
2.09%2.51B
6.14%2.58B
88.83%2.55B
81.64%2.51B
89.13%2.46B
90.35%2.43B
--1.35B
11.35%1.38B
6.42%1.3B
5.73%1.28B
Total liabilityies and equity
0.59%3.01B
4.66%3.12B
65.12%3.09B
61.65%3.13B
62.36%2.99B
65.15%2.98B
--1.87B
8.27%1.94B
5.03%1.84B
5.93%1.8B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Assets
Current assets
Money funds -18.44%755.15M-25.32%1.13B96.47%1.15B36.93%822.12M--925.85M274.14%1.51B--583.7M29.86%600.39M----19.70%403.78M
Transactional financial assets -23.07%509.25M448.05%329.27M829.31%372.37M7,523.92%762.41M--662M-57.22%60.08M--40.07M-88.91%10M-----43.90%140.45M
Notes receivable and accounts receivable 16.69%99.2M-18.92%88.97M-9.40%74.27M39.69%96.68M--85.01M21.57%109.72M--81.97M-23.87%69.21M----33.49%90.26M
-Accounts receivable 16.69%99.2M-18.92%88.97M-9.40%74.27M39.69%96.68M--85.01M21.57%109.72M--81.97M-23.87%69.21M----33.49%90.26M
Other receivables (including interest and dividends) 113.45%16.11M-5.45%6.74M-60.85%8.21M-65.94%6.21M--7.55M-59.83%7.13M--20.96M4.59%18.23M-----1.63%17.75M
-Other receivable -----5.45%6.74M-------------59.83%7.13M----4.59%18.23M-----1.63%17.75M
Contractual assets --75.44K--72.77K--114.2K--53.46K------------------------
Advance payment -33.84%817.13K27,689.39%722.52K-88.64%1.1M-99.34%69.52K--1.24M-99.97%2.6K--9.67M56.57%10.46M----37.13%7.87M
Inventories 29.73%46.94M21.93%38.8M31.38%39.6M-1.14%31.34M--36.18M16.19%31.82M--30.15M11.57%31.7M-----2.84%27.38M
Other current assets 5.55%18.98M32.44%18.33M735.76%27.84M570.89%14.73M--17.98M384.89%13.84M--3.33M-35.25%2.2M----63.22%2.85M
Total current assets -16.67%1.45B-7.05%1.61B116.97%1.67B133.58%1.73B--1.74B151.08%1.73B--769.85M6.13%742.19M-----2.63%690.35M
Non Current assets
Long-term equity investment ------------------10.73M-0.42%10.52M--10.53M--------0.60%10.56M
Fixed assets ----9.52%213.33M-------------9.44%194.78M-----1.04%217.41M----3.57%215.08M
Constru in process ----75.89%502.95M------------41.84%285.95M----54.46%236.16M----138.33%201.6M
Intangible assets -1.14%499.84M-1.26%502.86M25.44%503.42M24.77%503.88M--505.59M24.41%509.29M--401.32M-2.54%403.84M-----2.46%409.37M
Goodwill 67.32%25.39M67.32%25.39M67.32%25.39M67.32%25.39M--15.17M0.00%15.17M--15.17M0.00%15.17M----0.00%15.17M
Long deferred expense 302.10%101.64M276.66%98.62M239.15%91.1M203.82%87.43M--25.28M-15.87%26.18M--26.86M-3.49%28.78M-----8.81%31.12M
Deferred tax assets -36.85%9.29M-3.40%14.74M2.88%15.64M3.00%14.76M--14.71M25.96%15.26M--15.2M20.50%14.33M----17.03%12.11M
Usufruct assets -19.80%129.95M-20.25%137.34M-18.97%145.86M-18.62%154.41M--162.03M-17.42%172.2M--180M-15.49%189.74M----6.83%208.54M
Other non current assets 130.84%28.55M-36.50%8.78M-19.26%8.18M-89.66%9.44M--12.37M64.48%13.82M--10.13M625.51%91.23M-----44.13%8.4M
Total non current assets 24.45%1.56B20.98%1.5B28.91%1.42B17.03%1.4B--1.25B11.80%1.24B--1.1B9.64%1.2B----12.05%1.11B
Total assets 0.59%3.01B4.66%3.12B65.12%3.09B61.65%3.13B62.36%2.99B65.15%2.98B--1.87B8.27%1.94B5.03%1.84B5.93%1.8B
Liabilities
Current liabilities
Notes payable and accounts payable -0.71%185.52M5.39%209.59M18.30%209.98M52.11%252.58M--186.84M24.31%198.87M--177.5M17.59%166.05M----27.10%159.98M
-Accounts payable -0.71%185.52M5.39%209.59M18.30%209.98M52.11%252.58M--186.84M24.31%198.87M--177.5M17.59%166.05M----27.10%159.98M
Contract liabilities -1.76%6.04M6.27%8.21M12.36%8M15.14%6.15M--6.15M12.15%7.73M--7.12M4.72%5.34M----4.75%6.89M
Advance receipts --72K------------------------------------
Salaries payable 23.12%77.27M23.07%65.57M28.29%50.25M78.92%87.4M--62.76M36.38%53.28M--39.17M-32.05%48.85M-----22.31%39.06M
Taxs payable -21.86%7.95M26.15%13.2M35.56%16.78M116.52%11.07M--10.17M53.44%10.46M--12.38M96.27%5.11M-----35.45%6.82M
Other payable (including interest and dividends) -2.51%31.02M-23.72%28.84M-9.65%32.85M-42.24%44.61M--31.82M9.43%37.81M--36.36M108.44%77.23M-----10.61%34.55M
-Other payable -----23.72%28.84M------------9.43%37.81M----108.44%77.23M-----10.61%34.55M
Non current liabilities due within one year 31.52%36.15M2.49%38.31M-14.76%30.67M1.01%40.62M--27.49M12.76%37.38M--35.98M23.26%40.22M----48.26%33.15M
Total current liabilities 5.78%344.02M5.26%363.72M12.97%348.53M29.06%442.43M--325.23M23.20%345.53M--308.5M18.01%342.8M----10.28%280.46M
Current liabilities
Long term account payable ----3.20%14.67M-------------11.28%14.22M-----11.28%13.89M-----9.73%16.03M
Specific account payable ----14.44%3.02M-------------52.60%2.64M-----36.56%3.5M----2.48%5.57M
Estimate liabilities -56.09%11.74M22.59%32.76M26.88%33.98M18.28%32.08M--26.74M-4.52%26.73M--26.78M-10.88%27.12M-----0.62%27.99M
Deferred tax liabilities -98.31%19.05K-92.72%76.98K51.93%745.19K--101.13K--1.13M56.77%1.06M--490.47K---------40.20%674.22K
Long term deferred income 29.16%5.43M34.84%5.55M3.03%4.83M-4.39%3.77M--4.2M-50.55%4.11M--4.69M-45.83%3.95M-----8.56%8.32M
Lease liabilities -22.04%114.15M-23.59%116.83M-21.17%128.52M-20.63%132.36M--146.42M-18.26%152.91M--163.03M-16.86%166.77M----4.86%187.06M
Total non current liabilities -25.93%150.56M-14.26%172.92M-10.14%190.61M-14.73%183.52M--203.27M-17.90%201.67M--212.13M-17.28%215.23M----2.36%245.64M
Total liabilities -6.42%494.58M-1.93%536.63M3.56%539.14M12.17%625.95M-2.15%528.5M4.01%547.2M--520.63M1.34%558.03M1.82%540.12M6.44%526.1M
Shareholders equity
Paid-in capital 30.00%205.99M30.00%205.99M33.33%158.45M33.33%158.45M--158.45M33.33%158.45M--118.84M0.00%118.84M----0.00%118.84M
Capital reserve funds -3.83%1.63B-3.83%1.63B147.08%1.69B134.48%1.69B--1.7B150.82%1.7B--685.35M6.63%721.22M----0.05%676.35M
Surplus reserve funds 25.48%9.76M25.48%9.76M25.48%9.76M25.48%9.76M--7.78M19.35%7.78M--7.78M19.35%7.78M----21.24%6.52M
Retained profit 20.16%554.85M19.36%516.92M20.01%499.37M19.60%465.35M--461.74M20.43%433.08M--416.12M18.77%389.09M----19.83%359.62M
Less:Treasury stock --104.19M------------------------------------
Shareholders equity without minority interests -1.14%2.3B2.98%2.36B92.24%2.36B87.94%2.32B96.02%2.32B97.69%2.3B--1.23B9.53%1.24B--1.19B5.54%1.16B
Minority interests 56.60%215.73M60.44%214.2M54.92%191.45M27.49%183.44M--137.76M16.20%133.51M--123.58M29.91%143.89M----7.65%114.9M
Total shareholder equity 2.09%2.51B6.14%2.58B88.83%2.55B81.64%2.51B89.13%2.46B90.35%2.43B--1.35B11.35%1.38B6.42%1.3B5.73%1.28B
Total liabilityies and equity 0.59%3.01B4.66%3.12B65.12%3.09B61.65%3.13B62.36%2.99B65.15%2.98B--1.87B8.27%1.94B5.03%1.84B5.93%1.8B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme Brain science (brain-computer interface)
Brain science (brain-computer interface)
Intraday+2.20%
Smart Healthcare
Smart Healthcare
Intraday+0.66%